Clinical Trials Directory

Trials / Completed

CompletedNCT07025343

Does Intralipid Infusion Can Reverse the Spinal Anesthesia Effect in Day Case Surgery?

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
200 (actual)
Sponsor
Benha University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

This study aims to evaluate the effect of intralipid infusion on reversing the spinal anesthesia effect in day case surgery.

Detailed description

The increasing demand for day-case surgery has led to a growing interest in developing strategies to provide patients with a more convenient, cost-effective, and less invasive alternative to traditional inpatient procedures. Spinal anesthesia, in particular, is a widely used technique in day-case surgery due to its ability to provide excellent analgesia with minimal side effects. Intravenous lipid emulsion therapy is commonly used to treat local anesthetic systemic toxicity (LAST) and has demonstrated some efficacy in treating other drug toxicities, particularly cardiotoxicity from lipophilic drugs.

Conditions

Interventions

TypeNameDescription
OTHERLipid emulsionPatients (\>70kg will receive 100 ml, \<70 will receive 1.5ml/kg) of 20% intravenous lipid emulsion at the end of surgery as a study group.

Timeline

Start date
2025-02-01
Primary completion
2025-08-31
Completion
2025-08-31
First posted
2025-06-17
Last updated
2025-12-08

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT07025343. Inclusion in this directory is not an endorsement.